Medigen Vaccine Biologics Corp., a subsidiary of Medigen Biotechnology Corp. announced on March 17, 2026 that ENVACGEN®, an Enterovirus 71 (EV-A71) vaccine, has received marketing authorization from the Drug Administration of Vietnam (DAV).

For more information, please refer to the following links:
Medigen Vaccine Biologics Corp. website: https://www.medigenvac.com/news_view.php?id=267
Commercial Times: https://www.ctee.com.tw/news/20260318700185-439901
Economic Daily News: https://money.udn.com/money/story/5612/9386456